Crestor® Warning: In 2005, the Food and Drug Administration (FDA) issued an updated Crestor® Warning to further explain the risks and benefits of this cholesterol lowering drug. The public health advisory states Crestor® will now carry a new label that includes new recommended doses for people at a higher risk of muscle damage. A Crestor® Warning is part of a continuing effort to alert the public of potentially significant emerging safety data so they can make more informed decisions about their medical care. Time is an important factor when trying to protect your rights.
Crestor® is in a class of drugs called statins, which work by stopping an enzyme called HMG-CoA reductase from making cholesterol. Crestor® medications work in conjunction with a low fat diet and an exercise program, therefore reducing “bad” cholesterol (LDL) which is a known risk factor for heart attacks, strokes and heart disease. It was also advertised for raising the level of “good” cholesterol (HDL) in many cases. Now, after years of use by the public, a Crestor® Warning is in order to notify consumers of the significant risk potential of Crestor® medications.
A call for the FDA to ban the cholesterol lowering drug, Crestor®, has been renewed by the group Public Citizen, citing possible new cases of patients with life-threatening side effects. The group, Public Citizen is a not associated with the FDA or the manufacturer. In operation since 1971, the non-profit, public interest group has been assessing the quality and safety of drugs on behalf consumers. In 2005 and again recently, they have expressed concern about Crestor® Medications. Public Citizen believes the Crestor® side effects could prove incapacitating or even deadly.
A Crestor® Warning should suggest to patients and prescribers, a careful evaluation of the risks involved when taking Crestor® Medications. One of the side effects of Crestor® is Rhabdomyolysis and occurs when a large number of skeletal muscle cells die. The death of the skeletal muscle cells results in the release of a massive amount of muscle protein into the bloodstream. This flood of muscle protein in the blood leads to the deadliest of Crestor® side effects. The muscle protein becomes trapped in the kidneys, affecting the filtering process of the kidneys leading to possible, if not probable, kidney failure. Other related side effects include cardiac arrest resulting from potassium released from the damaged muscle cells.
Crestor® side effects have been the subject of much recent controversy, perhaps more so than any other cholesterol lowering medication introduced to date. Despite numerous objections due to safety concerns, the drug was approved by the FDA in August of 2003, and launched a month later. The consequences of taking Crestor® medications are significant, possibly life altering, potentially lethal and include: cardiomyopathy, myopathy, necrotizing myopathy, heart attack, type 2 diabetes, sudden cardiac death, kidney failure and death from a heart related condition. The risks are overwhelming and have led to an outcry and demand for a Crestor® recall, by the public interest group, Public Citizen. Crestor® has not been recalled and it is not known at this time if a recall will be made.
Support Line: 1-800-611-7080
www.crestorwarning.com